Angioimmunoblastic T-cell lymphoma laboratory tests: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Laboratory tests for angioimmunoblastic T-cell lymphoma include [[complete blood count | [[Medical laboratory|Laboratory]] [[Test|tests]] for angioimmunoblastic T-cell lymphoma include [[complete blood count|complete blood count (CBC)]], [[Hypergammaglobulinemia|polyclonal hypergammaglobulinemia]], [[FISH]], [[blood]] chemistry studies, [[flow cytometry]], [[immunohistochemistry]], and [[immunophenotyping]]. | ||
==Laboratory Tests== | ==Laboratory Tests== | ||
Laboratory tests for angioimmunoblastic T-cell lymphoma include:<ref name= seer >Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015</ref> | [[Medical laboratory|Laboratory]] [[Test|tests]] for angioimmunoblastic T-cell lymphoma include:<ref name="seer">Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015</ref> | ||
* [[Complete blood count]] (CBC) | * [[Complete blood count]] (CBC) | ||
:* [[Anemia]] | :* [[Anemia]] | ||
:* [[Eosinophilia]] | :* [[Eosinophilia]] | ||
* Polyclonal [[hypergammaglobulinemia]] | * Polyclonal [[hypergammaglobulinemia]] | ||
* Blood chemistry studies | * [[Blood]] chemistry studies | ||
* [[Flow cytometry]] | * [[Flow cytometry]] | ||
* [[Immunohistochemistry]] | * [[Immunohistochemistry]] | ||
* Fluorescence in situ hybridization ( | * [[Fluorescence in situ hybridization|Fluorescence in situ hybridization (FISH]]) | ||
:* Negative for the Epstein-Barr virus ( | :* Negative for the [[Epstein Barr virus|Epstein-Barr virus (EBV]]) | ||
* Immunophenotyping | * [[Immunophenotyping]] | ||
:* Positivity for [[CD2]], [[CD3]], [[CD4]], [[CD5]], [[CD10]], [[CD20]] and focal positivity for [[CXCL13]] | :* Positivity for [[CD2]], [[CD3]], [[CD4]], [[CD5]], [[CD10]], [[CD20]], and focal positivity for [[CXCL13]] | ||
:* Negative for ALK1 and [[CD30]] | :* Negative for ALK1 and [[CD30]] | ||
==References== | ==References== | ||
| Line 26: | Line 26: | ||
[[Category:Pathology]] | [[Category:Pathology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 18:50, 1 April 2019
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma laboratory tests |
|
Angioimmunoblastic T-cell lymphoma laboratory tests in the news |
|
Blogs on Angioimmunoblastic T-cell lymphoma laboratory tests |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
|
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Laboratory tests for angioimmunoblastic T-cell lymphoma include complete blood count (CBC), polyclonal hypergammaglobulinemia, FISH, blood chemistry studies, flow cytometry, immunohistochemistry, and immunophenotyping.
Laboratory Tests
Laboratory tests for angioimmunoblastic T-cell lymphoma include:[1]
- Complete blood count (CBC)
- Polyclonal hypergammaglobulinemia
- Blood chemistry studies
- Flow cytometry
- Immunohistochemistry
- Fluorescence in situ hybridization (FISH)
- Negative for the Epstein-Barr virus (EBV)
References
- ↑ Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015